DX Group
DX
$12.18
-0.90%
Dynex Capital, Inc. is an internally managed mortgage real estate investment trust (REIT) that invests primarily in residential and commercial mortgage-backed securities (RMBS and CMBS), overwhelmingly Agency securities guaranteed by U.S. government-sponsored enterprises, funded through repurchase agreements and equity. With only 28 employees and a market capitalization of roughly $1.7-3.2 billion, it is a small, highly specialized niche player in the mortgage REIT space, distinguished by its internally managed structure (avoiding external management fees), active risk management of interest rate, prepayment, spread, liquidity, and counterparty risk, and a long operating history dating back to its 1988 listing. The current investor narrative is dominated by the tension between an exceptionally high dividend yield of roughly 14.2% and a book-value-focused valuation (price-to-book near 0.71x), set against a challenging rate environment that has produced volatile quarterly earnings — a large Q1 2026 net loss of $80.4 million following a strong Q4 2025 profit of $185.4 million — and persistent underperformance versus the S&P 500. Attention is also focused on the company's aggressive balance sheet expansion, with shares outstanding rising from roughly 90 million in Q1 2025 to over 200 million by Q1 2026 and total assets growing sharply through repeated common stock issuance and repo-funded MBS purchases, raising questions about dilution, leverage, and the sustainability of the dividend if spread income does not keep pace.…
DX
DX Group
$12.18
Investment Opinion: Should I buy DX Today?
The synthesized recommendation is a Hold with a value/income tilt. The core thesis is that DX offers a 14.18% dividend yield and trades at a 29.4% discount to book value (0.706x P/B), but near-term earnings volatility, high leverage, and negative momentum offset the appeal. The analyst consensus average target of $14.75 implies +21.1% upside, and all five analysts have targets above the current price, suggesting the sell-side sees recovery potential. However, the lack of a formal consensus recommendation and the small analyst cohort mean this signal is less robust.
Supporting evidence for a Hold includes: (1) valuation at 0.706x book, near the low end of its historical range, which could attract value buyers; (2) a 14.18% dividend yield with a 77.3% payout ratio, covered by TTM free cash flow of $184.3 million; (3) a forward PE of 7.77x and trailing PE of 5.63x, which screen cheap versus the broad REIT sector; and (4) a 12.96% ROE and 2.31% ROA, respectable for a mortgage REIT. However, these positives are tempered by a Q1 2026 net loss of $80.4 million, a debt-to-equity ratio of 5.65x, and a share count that doubled in a year, diluting per-share value.
The biggest risks that could invalidate the thesis are a dividend cut, a sustained increase in mortgage spreads that erodes book value, and a breakdown below the 52-week low of $11.83. The rating would upgrade to Buy if the stock stabilizes above $13.00 and book value remains stable for two consecutive quarters, or if the P/B discount narrows toward 0.80x. It would downgrade to Sell if the dividend is cut or if book value per share declines by more than 5% in a quarter. Relative to its history and peers, DX appears undervalued on a P/B basis, but the discount is justified by elevated leverage and earnings volatility, making it a speculative income play rather than a core holding.
Sign up to view all
DX 12-Month Price Forecast
DX presents a classic deep-value income opportunity with significant caveats. The 0.706x P/B and 14.18% yield are attractive, but the Q1 2026 loss, 5.65x leverage, and doubling of share count raise concerns about sustainability. The analyst community is uniformly bullish with a $14.75 average target, but the lack of a formal consensus and the small cohort reduce the signal's strength. The stock's negative momentum and underperformance versus SPY suggest the market is pricing in real risks. I would upgrade to bullish if book value stabilizes and the dividend is covered by net interest income for two consecutive quarters; I would downgrade to bearish if the dividend is cut or if book value declines by more than 5% in a quarter.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on DX Group's 12-month outlook, with a consensus price target around $14.75 and implied upside of +21.1% versus the current price.
Average Target
$14.75
0 analysts
Implied Upside
+21.1%
vs. current price
Analyst Count
—
covering this stock
Price Range
$15 - $15
Analyst target range
Five analysts cover Dynex Capital, and the consensus is constructive: the average target price is $14.75, with a low of $14.50 and a high of $15.00. Against the current price of $12.18, the average target implies upside of approximately +21.1%, and even the low target of $14.50 implies +19.0% upside — a uniformly bullish signal with no analyst target below the current price. The recommendation field is listed as "none," but the institutional ratings history shows a consistent pattern of Buy/Outperform ratings from Jones Trading (Buy) and Keefe, Bruyette & Woods (Outperform) alongside Neutral ratings from UBS, indicating a moderately bullish but not unanimous stance. The consensus estimated EPS of $1.676 for the forward period, versus the current trailing EPS of $0.183, implies analysts expect a substantial earnings recovery.
The target range is unusually tight — only $0.50 separates the low of $14.50 from the high of $15.00, a spread of just 3.4% of the average — which signals strong conviction among the small analyst cohort rather than high uncertainty. The high target of $15.00 would require the stock to reclaim its 52-week high of $14.93 and likely assumes book value stability, successful deployment of the newly raised capital into accretive MBS purchases, and a favorable rate/spread environment that restores earnings toward the $1.68 consensus EPS estimate. The low target of $14.50 still prices in meaningful recovery and does not appear to embed a bear case of margin compression or book-value erosion, which is a notable limitation given the Q1 2026 loss and 5.65x leverage. The institutional ratings show no downgrades in the past year — UBS has stayed Neutral since at least September 2025 while Jones Trading and KBW have maintained Buy/Outperform — suggesting stable sentiment, but the small number of covering analysts (five) and the absence of a formal consensus recommendation mean price discovery may be less efficient and the stock could be more sensitive to changes in a single analyst's view.
Bulls vs Bears: DX Investment Factors
The bear case currently has stronger near-term evidence: DX is down -13.49% YTD, trading near its 52-week low of $11.83, with accelerating negative momentum (-8.63% in one month) and a Q1 2026 net loss of $80.4 million. However, the bull case rests on a compelling valuation anchor — 0.706x book value — and unanimous analyst targets implying +21.1% upside, supported by a 14.18% dividend yield. The single most important tension is whether book value per share remains stable; if it does, the discount to book and high yield offer a powerful mean-reversion opportunity, but if book value erodes due to spread widening or hedging losses, the discount could persist or deepen. The resolution of this tension will determine whether DX is a value trap or a deep-value income play.
Bullish
- Deep discount to book value: DX trades at 0.706x price-to-book, near the low end of its historical 0.68x-0.94x range and below the typical 0.7x-1.1x band for Agency MBS REITs. For a portfolio of government-guaranteed securities, this discount implies the market is pricing in credit or spread stress that may not materialize, offering potential mean-reversion upside if book value holds.
- Uniformly bullish analyst targets: All five covering analysts have targets between $14.50 and $15.00, with an average of $14.75 implying +21.1% upside from $12.18. Even the low target implies +19.0% upside, and the unusually tight $0.50 range signals high conviction rather than dispersed uncertainty.
- 14.2% dividend yield with 77% payout: The 14.18% dividend yield is exceptionally high, and the payout ratio of 77.3% is covered by TTM free cash flow of $184.3 million. While not a large cushion, the payout appears sustainable as long as net interest spread income remains positive and book value is stable.
- Earnings recovery expected: Consensus forward EPS of $1.676 compares to trailing EPS of just $0.183, implying analysts expect a substantial rebound from the Q1 2026 loss of $80.4 million. If realized, the forward PE of 7.77x would look inexpensive for a company with 12.96% ROE.
Bearish
- Severe earnings volatility and Q1 loss: Q1 2026 produced a net loss of $80.4 million (EPS -$0.41) driven by a $317.3 million negative swing in other income/expenses, following a $185.4 million profit in Q4 2025. This swing illustrates that earnings are dominated by mark-to-market and hedging noise rather than a stable operating stream.
- Massive dilution from share issuance: Shares outstanding more than doubled from roughly 90.5 million in Q1 2025 to 200.1 million in Q1 2026, funding a rapid balance sheet expansion. While this grows the asset base, it dilutes existing shareholders and raises the bar for per-share earnings and book value accretion.
- High leverage and thin liquidity: Debt-to-equity stands at 5.65x with total debt-to-capitalization near 88.6%, typical for Agency MBS REITs but still elevated. The reported current ratio of 0.0 and quick ratio of 0.064 highlight reliance on repo funding and the need for continuous rollover, which can be disrupted in stressed markets.
- Persistent underperformance and weak momentum: DX has underperformed SPY by -16.55 percentage points over one year and -25.19 points YTD, with the stock down -13.49% YTD and trading at just 10.7% of its 52-week range. The 1-month decline of -8.63% is steeper than the 1-year decline of -1.54%, indicating accelerating negative momentum.
DX Technical Analysis
Dynex Capital is in a mild, range-bound downtrend rather than a sustained directional move. The stock's 1-year price change is -1.54%, and at the current price of $12.18 it sits at just 10.7% of its 52-week range of $11.83 to $14.93, meaning it is trading very close to the bottom of its annual range. That positioning near the 52-week low, combined with a YTD decline of -13.49%, suggests the stock is closer to a value/mean-reversion candidate than a momentum leader, though the proximity to the low also raises the risk of a breakdown if support fails. The 52-week high of $14.93 was set earlier in the period, and the failure to reclaim even the mid-range (~$13.38) indicates persistent seller pressure.
Short-term momentum has deteriorated sharply and is diverging negatively from the already-weak longer-term trend. The 1-month change is -8.63% and the 3-month change is -6.74%, both worse than the 1-year change of -1.54%, meaning the decline is accelerating rather than stabilizing. This is corroborated by relative strength: DX has underperformed SPY by -7.67 percentage points over 1 month, -8.74 points over 3 months, and -16.55 points over 1 year, while SPY itself gained 15.01% over the past year. The recent slide from $13.33 on August 19 to $12.18 on September 18 — a roughly 8.6% drop in a month — on elevated volume of 14.88 million shares signals distribution rather than accumulation, and the stock closed near its recent low at $12.18 versus the prior close of $12.29.
Key technical levels are well defined: support sits at the 52-week low of $11.83, just 2.9% below the current $12.18 price, while resistance is the 52-week high of $14.93, roughly 22.6% above. A breakdown below $11.83 would likely trigger momentum-driven selling and open the door to new lows, whereas a reclaim of the $13.00-$13.30 area would be the first sign of stabilization and a move toward $14.93 would require a fundamental catalyst. Volatility is moderate relative to the market, with a beta of 0.935 — about 6.5% less volatile than SPY — which argues for smaller position-sizing adjustments than a high-beta name, but the maximum drawdown of -17.5% shows the stock can still inflict meaningful losses. The short ratio of 2.71 indicates short interest is present but not extreme, so a short squeeze is not a primary risk driver at current levels.
Beta
0.94
0.94x market volatility
Max Drawdown
-17.5%
Largest decline past year
52-Week Range
$12-$15
Price range past year
Annual Return
-1.5%
Cumulative gain past year
| Period | DX Return | S&P 500 |
|---|---|---|
| 1m | -8.6% | -0.5% |
| 3m | -6.7% | +2.3% |
| 6m | -1.7% | +16.6% |
| 1y | -1.5% | +14.8% |
| ytd | -13.5% | +11.7% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
DX Fundamental Analysis
Dynex Capital's revenue trajectory is erratic and driven by spread and mark-to-market dynamics rather than a stable operating business. Q1 2026 revenue was $257.4 million, up 170.8% year-over-year from $95.1 million in Q1 2025, but the sequential trend is highly uneven: revenue went from $95.1 million (Q1 2025) to $111.7 million (Q2 2025) to $149.7 million (Q3 2025) to $177.0 million (Q4 2025) before jumping to $257.4 million in Q1 2026. The growth is largely a function of a rapidly expanding investment portfolio funded by equity issuance — shares outstanding rose from about 90.5 million in Q1 2025 to 200.1 million in Q1 2026 — rather than organic improvement in net interest spread, so the headline revenue growth overstates the economic quality of the expansion. No revenue segment data is available, consistent with the company operating as a single reportable MBS investment segment.
Profitability is highly volatile and currently negative at the net level despite strong operating margins. Q1 2026 produced a net loss of $80.4 million (EPS -$0.41) against operating income of $236.9 million, with the loss driven by a $317.3 million negative swing in total other income/expenses — the mark-to-market and hedging line — rather than by core operations. Gross margin is reported at 100% and operating margin at 138.4%, but these figures are not meaningful for a mortgage REIT because revenue is essentially interest income and the true economics are captured in net interest spread and book value changes. The quarterly pattern is stark: net income of -$3.1 million (Q1 2025), -$13.6 million (Q2 2025), +$150.4 million (Q3 2025), +$185.4 million (Q4 2025), and -$80.4 million (Q1 2026), showing that earnings are dominated by rate-driven unrealized gains and losses rather than a stable earnings stream.
The balance sheet is the key risk: debt-to-equity stands at 5.65x and the total debt-to-capitalization ratio is roughly 88.6%, reflecting the repo-funded leverage typical of Agency MBS REITs but still elevated. Liquidity is thin on a current-ratio basis (0.0 reported, with a quick ratio of 0.064 in the Q1 2026 historical data), though the company held $1.29 billion of cash at the end of Q1 2026 after raising $441.7 million of common stock and $7.48 billion of net financing. Free cash flow is positive but modest relative to the dividend: TTM free cash flow is $184.3 million versus $102.5 million of dividends paid in Q1 2026 alone, and the payout ratio of 77.3% leaves limited cushion. ROE of 12.96% and ROA of 2.31% are respectable for the sector, but the dividend yield of 14.18% is well above what current earnings power comfortably supports, meaning the payout depends on continued spread income and stable book value.
Quarterly Revenue
$257390000.0B
2026-03
Revenue YoY Growth
+170.8%
YoY Comparison
Gross Margin
100.0%
Latest Quarter
Free Cash Flow
$184307000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Open an Account, get $2 TSLA now!
Valuation Analysis: Is DX Overvalued?
Because Dynex Capital reported positive trailing net income (EPS of $0.183 on a trailing basis, with net income positive over the trailing period despite the Q1 2026 loss), the PE ratio is the appropriate primary metric, though for a mortgage REIT the price-to-book ratio is arguably more informative. The trailing PE is 5.63x and the forward PE is 7.77x, an unusual configuration in which the forward multiple is higher than the trailing multiple — implying the market expects earnings to decline from the trailing level, consistent with the Q1 2026 loss and the volatility of mark-to-market gains. The PEG ratio of 0.085 is extremely low, but it is distorted by the unstable earnings base and should not be read as a straightforward value signal.
On a price-to-book basis, DX trades at 0.706x book value, a discount to book that is the most relevant valuation anchor for an Agency MBS REIT and is broadly in line with where the sector has traded in recent years (peers typically range from roughly 0.7x to 1.1x book depending on rate conditions). The PS ratio of 3.26x and EV/Sales of 50.1x are not meaningful for a levered balance-sheet business, and the EV/EBITDA of 19.9x reflects the heavy repo funding rather than operating profitability. Relative to the broad REIT sector, the 0.71x P/B and 5.6x trailing PE screen as inexpensive, but that discount is justified by the company's high leverage (debt-to-equity of 5.65x), volatile earnings, and the dilution from a share count that more than doubled in a year.
Historically, DX's price-to-book has ranged from roughly 0.68x (Q4 2022) to 0.94x (Q1 2026) over the past several years, and the current 0.706x sits near the lower end of that band — closer to the 2022 lows than to the 2026 high. The trailing PE history is too erratic (ranging from negative readings to 12.7x) to be a reliable band, which reinforces using P/B as the historical anchor. Trading near the bottom of its own P/B range suggests the market is pricing in either a value opportunity if book value holds, or fundamental deterioration if credit/spread conditions worsen; the 14.18% dividend yield and 77.3% payout ratio mean the margin for error is thin, and a sustained P/B below 0.70x would signal the market doubts book value stability.
PE
5.6x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range 1x~13x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
19.9x
Enterprise Value Multiple
Investment Risk Disclosure
Dynex Capital's financial and operational risks are dominated by its highly levered balance sheet and volatile earnings. Debt-to-equity of 5.65x and a debt-to-capitalization ratio of 88.6% mean that small changes in asset values can have an outsized impact on equity, and the reported current ratio of 0.0 with a quick ratio of 0.064 indicates thin liquidity buffers. Earnings are extremely erratic: Q1 2026 swung to a net loss of $80.4 million from a $185.4 million profit in Q4 2025, driven by a $317.3 million negative swing in other income/expenses. The dividend payout ratio of 77.3% leaves little cushion, and with TTM free cash flow of $184.3 million against $102.5 million of dividends paid in Q1 2026 alone, any sustained spread compression could force a dividend cut. Additionally, the share count more than doubled from 90.5 million to 200.1 million in a year, diluting per-share metrics and raising the earnings bar needed to sustain the dividend.
Market and competitive risks center on valuation compression and macro sensitivity. DX trades at 0.706x book value, near the low end of its historical 0.68x-0.94x range, which could reflect justified skepticism about book value stability rather than a pure discount. The stock's beta of 0.935 indicates moderate correlation to the market, but its underperformance versus SPY (-16.55 percentage points over one year) highlights sector rotation risk away from mortgage REITs. Competitive dynamics are less of a concern given the Agency MBS focus, but regulatory changes to GSE guarantees or repo market structure could alter the risk-reward. Recent news is absent, but the broader environment of volatile interest rates and potential Fed policy shifts remains a key external threat that could widen spreads and pressure book value.
The worst-case scenario would involve a combination of widening mortgage spreads, hedging losses, and a dividend cut, leading to a breakdown below the 52-week low of $11.83. From the current price of $12.18, a drop to the 52-week low represents a decline of about -2.9%, but if book value erodes and the stock trades down to a deeper discount (e.g., 0.60x book), the downside could be -15% to -20%. The maximum drawdown of -17.5% over the past year provides a historical reference for a severe sell-off. In a stress scenario where the dividend is cut and leverage forces asset sales, the stock could fall toward $10.00, implying a loss of roughly -18% from current levels. Investors should note that the analyst low target of $14.50 does not embed a bear case, so the true downside may be underappreciated by the sell-side.
FAQ
The most severe risk is a dividend cut, given the 77.3% payout ratio and reliance on net interest spread income; a cut would likely trigger a sharp price decline. Second, high leverage of 5.65x debt-to-equity amplifies losses if mortgage spreads widen or repo funding becomes scarce, potentially forcing asset sales at unfavorable prices. Third, earnings volatility is extreme, as shown by the Q1 2026 net loss of $80.4 million versus Q4 2025 profit of $185.4 million, making it difficult to predict future performance. Fourth, dilution from share issuance—shares outstanding rose from 90.5 million to 200.1 million in a year—dilutes per-share metrics and reduces the earnings power needed to sustain the dividend. These risks are ranked from most to least severe, with dividend sustainability being the primary concern.
The 12-month forecast has three scenarios: a bull case (25% probability) targeting $14.50-$15.00 if spreads tighten and book value stabilizes; a base case (50% probability) targeting $12.50-$14.00 if the dividend is maintained but earnings remain volatile; and a bear case (25% probability) targeting $10.00-$11.83 if spreads widen and the dividend is cut. The base case is most likely, assuming no severe market disruption and stable book value. The key assumption is that net interest spread income continues to cover the dividend, preventing a cut. Analyst targets average $14.75, but the bear case is not reflected in sell-side estimates, suggesting downside risk may be underappreciated.
DX appears undervalued on a price-to-book basis, trading at 0.706x book value, which is near the low end of its historical range of 0.68x-0.94x and below the typical 0.7x-1.1x band for Agency MBS REITs. The trailing PE of 5.63x and forward PE of 7.77x also screen cheap, though the forward multiple being higher than trailing implies expected earnings decline. The 14.18% dividend yield is well above the sector average, suggesting the market is pricing in significant risk. However, the discount is justified by high leverage (5.65x debt-to-equity), volatile earnings, and dilution. If book value remains stable, the stock is undervalued; if book value erodes, the discount could widen further. The market is currently pricing in a high probability of dividend cut or book value impairment.
DX offers a compelling 14.18% dividend yield and trades at a 29.4% discount to book value (0.706x P/B), with analyst targets implying +21.1% upside to $14.75. However, the company reported a Q1 2026 net loss of $80.4 million, carries 5.65x debt-to-equity, and has more than doubled its share count in a year, diluting per-share value. The stock is down -13.49% YTD and near its 52-week low of $11.83, reflecting significant market skepticism. For income-focused investors with a high risk tolerance, the yield and discount may be attractive, but the dividend sustainability is not guaranteed. It is a speculative buy at best, suitable only for those who can withstand further downside toward $10-$11 if spreads widen or the dividend is cut.
DX is more suitable for medium- to long-term income-focused investors than for short-term traders. The 14.18% dividend yield and 0.706x P/B discount require time to play out, and the stock's beta of 0.935 and moderate volatility make it less ideal for short-term speculation. However, the high leverage and earnings volatility mean it is not a buy-and-forget holding; investors should monitor book value and dividend coverage quarterly. A minimum holding period of 2-3 years is suggested to capture the yield and potential mean reversion, but only if the dividend remains intact. Short-term traders might exploit range-bound moves between $11.83 and $14.93, but the risk of a breakdown below support is significant.